Increased cycle length variability during ventricular fibrillation: a novel predictor of arrhythmia recurrence

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Ventricular fibrillation (VF) cycle length (CL) variability is a potential indicator of electrical heterogeneity.
• Understanding VF CL variability can aid in predicting arrhythmic events and optimizing implantable cardioverter defibrillator (ICD) therapy.

Purpose of the Study:

• To evaluate the clinical significance of VF CL variability in predicting recurrent ventricular arrhythmias.
• To assess the utility of mean successive differences (MSD) and coefficient of variation (CV(FF)) of VF CL as predictors of arrhythmia recurrence.

Main Methods:

• Analysis of VF CL, MSD, and CV(FF) in 26 patients undergoing ICD implantation.
• Calculation of VF CL variability parameters during induced VF for defibrillation testing and programmed ventricular stimulation.
• Application of Bland-Altman method for assessing repeatability of VF CL variability measures.
• Kaplan-Meier estimates and multivariate analysis to determine predictive value for arrhythmia recurrence.

Main Results:

• Patients with recurrent ventricular arrhythmias exhibited significantly higher MSD and CV(FF) compared to those without recurrence.
• MSD >= 20 ms and CV(FF) >= 12 were identified as predictors of higher arrhythmia recurrence rates.
• CV(FF) >= 12 was a significant independent predictor of recurrent arrhythmic events by multivariate analysis.

Conclusions:

• Increased VF CL variability, quantified by MSD and CV(FF), is associated with a higher likelihood of arrhythmia recurrence.
• These variability measures may reflect underlying electrical heterogeneity and serve as valuable biomarkers for predicting future arrhythmic events.
• VF CL variability analysis holds potential for refining risk stratification and guiding therapeutic decisions in patients with ICDs.